Effect of transfusion therapy on cerebral vasculopathy in children with sickle-cell anemia

Haematologica

Volumn 94, Issue 1, 2009, Pages 123-126

  Bader Meunier, Brigitte ^a   Verlhac, Suzanne ^b   Elmaleh Bergès, Monique ^b   Ithier, Ghislaine ^b   Sellami, Fatiha ^b   Faid, Sonia ^b   Missud, Florence ^b   Ducrocq, Rolande ^b   Alberti, Corinne ^b,c   Zaccaria, Isabelle ^b,c   Baruchel, Andre ^b   Benkerrou, Malika ^b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b HÔPITAL ROBERT DEBRÉ   (France)

^c INSERM   (France)

Author keywords

Cerebral vasculopathy; Children; Sickle cell anemia; Stroke

Indexed keywords

ARTERY OCCLUSION; ARTICLE; BLOOD TRANSFUSION; BRAIN ARTERY; CEREBROVASCULAR DISEASE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MOYAMOYA DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SICKLE CELL ANEMIA;

ADOLESCENT; ANEMIA, SICKLE CELL; BLOOD TRANSFUSION; CEREBROVASCULAR DISORDERS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE;

EID: 58149269437     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.13610     Document Type: Article

References (13)

1. Wang WC, Kovnar EH, Tonkin IL, Mulhern RK, Langston JW, Day SW, et al. High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease. J Pediatr 1991;118:377-82.
2. Pegelow CH, Adams RJ, McKie V, Abboud M, Berman B, Miller ST, et al. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr 1995;126:896-9.
3. Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998;339:5-11.
4. Russell MO, Goldberg HI, Hodson A, Kim HC, Halus J, Reivich M, et al. Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease. Blood 1984;63:162-9.
5. Abboud MR, Cure J, Granger S, Gallagher D, Hsu L, Wang W, et al. STOP study. Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP study. Blood 2004;103:2822-6.
6. Dobson SR, Holden KR, Nietert PJ, Cure JK, Laver JH, Disco D, et al. Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events. Blood 2002;99:3144-50.
7. Bernaudin F, Verlhac S, Coic L, Lesprit E, Brugieres P, Reinert P. Long-term follow-up of pediatric sickle cell disease patients with abnormal high velocities on transcranial Doppler. Pediatr Radiol 2005;35:242-8.
8. Taylor JG 6th, Tang DC, Savage SA, Leitman SF, Heller SI, Serjeant GR, et al. Variants in the VCAM1 gene and risk for symptomatic stroke in sickle cell disease. Blood 2002;100:4303-9.
9. Switzer JA, Hess DC, Nichols FT, Adams RJ. Pathophysiology and treatment of stroke in sickle-cell disease: present and future. Lancet Neurol 2006;5:501-12.
10. Gladwin MT, Shelhamer JH, Ognibene FP, Pease-Fye ME, Nichols JS, Link B, et al. Nitric oxide donor properties of hydroxyurea in patients with sickle-cell disease. Br J Haematol 2002;116:436-44.
11. Gulbis B, Haberman D, Dufour D, Christophe C, Vermylen C, Kagambega F, et al. Sickle cell disease in children and for prevention of cerebrovascular events: the Belgian experience. Blood 2005;105:2685-90.
12. Zimmerman SA, Schultz WH, Burgett S, Mortier NA, Ware RE. Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia. Blood 2007;110:1043-7.
13. Furuyama H, Odagawa Y, Katoh C, Iwado Y, Ito Y, Noriyasu K, et al. Altered myocardial flow reserve and endothelial function late after Kawasaki disease. J Pediatr 2003;142:149-54.